Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
CDC Warns of Multistate Listeria Outbreak
All 10 infected people were hospitalized; one death reported in Florida
USPSTF Issues Draft Recommendation for CRC Screening
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years
Risk Factors ID’d for More Severe Depressive Symptoms During COVID-19 Pandemic
Physical, psychological abuse, preexisting health conditions, low social support, low SEP linked to risk
Decrease Seen in Non-COVID-19-Related Hospitalizations at Peak
Caseload of common medical emergencies, including acute MI, ischemic stroke also decreased
Metabolic Surgery Linked to Reduced Risk for MACE After MI
Risk for death, new MI, heart failure lower with metabolic surgery in obese patients with previous MI
ASN: Finerenone May Slow Progression in CKD With T2DM
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo
Recommendations Updated for HIV Treatment, Prevention
Prompt initiation of antiretroviral therapy advised in those with HIV and detectable viremia
COVID-19 Pandemic Challenges Osteoporosis Management
Decline in active management reflected by decrease in FRAX online fracture risk assessments
Rural Patients With Alzheimer Disease Have Shorter Survival
Rural versus urban patients also spend more time in nursing homes, receive less home health care
